Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Corcept Therapeutics Inc
Corcept Therapeutics Inc 019904

Corcept Therapeutics Inc patents


Recent patent applications related to Corcept Therapeutics Inc. Corcept Therapeutics Inc is listed as an Agent/Assignee. Note: Corcept Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Corcept Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Corcept Therapeutics Inc-related inventors


Differential diagnosis of ectopic cushing's syndrome

Improved methods and systems for diagnosing and for treating Cushing's syndrome and Cushing's Disease are provided herein, including methods and systems for concurrently treating Cushing's syndrome and differentially diagnosing Cushing's Disease from Ectopic Cushing's Syndrome in a patient with an established diagnosis of ACTH-dependent Cushing's syndrome. Treatment methods can use... Corcept Therapeutics Inc

Concomitant administration of glucocorticoid receptor modulators and cyp3a inhibitors

Subjects treated with CYP3A inhibitors or steroidogenesis inhibitors may suffer from toxicity or other serious adverse reactions; concomitant administration of other drugs would be expected to increase the risk of such toxicity and adverse reactions. Applicant has surprisingly found that GRAs may be administered to subjects receiving CYP3A inhibitors or... Corcept Therapeutics Inc

Concomitant administration of glucocorticoid receptor modulators and cyp3a or steroidogenesis inhibitors

Subjects treated with CYP3A inhibitors or steroidogenesis inhibitors may suffer from toxicity or other serious adverse reactions; concomitant administration of other drugs would be expected to increase the risk of such toxicity and adverse reactions. Applicant has surprisingly found that GRAs may be administered to subjects receiving CYP3A inhibitors or... Corcept Therapeutics Inc

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.... Corcept Therapeutics Inc

Method for differentially diagnosing acth-dependent cushing's syndrome

This invention provides for an improved method for differentially diagnosing ACTH-dependent Cushing's syndrome. Current practice for differentially diagnosing ectopic ACTH syndrome and Cushing's Disease measures relative ACTH concentrations from the inferior petrosal venous sinus compared to fluid obtained from a periphery venous sample. This is performed before and after administration... Corcept Therapeutics Inc

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.... Corcept Therapeutics Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Corcept Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Corcept Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###